Provided by Tiger Fintech (Singapore) Pte. Ltd.

Galectin Therapeutics

2.80
-0.0900-3.11%
Post-market: 2.800.00000.00%19:59 EDT
Volume:445.51K
Turnover:1.32M
Market Cap:177.22M
PE:-3.87
High:3.18
Open:2.89
Low:2.79
Close:2.89
Loading ...
Dec 06, 2021

Statement Of Changes In Beneficial Ownership

4 - Statement of changes in beneficial ownership of securities
Dec 06, 2021

Statement Of Changes In Beneficial Ownership

4 - Statement of changes in beneficial ownership of securities
Dec 01, 2021

Statement Of Changes In Beneficial Ownership

4 - Statement of changes in beneficial ownership of securities
Nov 15, 2021

Statement Of Changes In Beneficial Ownership

4 - Statement of changes in beneficial ownership of securities
Nov 04, 2021

Statement Of Changes In Beneficial Ownership

4 - Statement of changes in beneficial ownership of securities
Nov 01, 2021

Statement Of Changes In Beneficial Ownership

4 - Statement of changes in beneficial ownership of securities
Sep 21, 2021

Major Issues Report

8-K - Current report
Sep 13, 2021

Major Issues Report

8-K - Current report
Aug 16, 2021

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 16, 2021

Major Issues Report

8-K - Current report
Jul 26, 2021

Major Issues Report

8-K - Current report
Jul 09, 2021

Major Issues Report

8-K - Current report
May 17, 2021

Major Issues Report

8-K - Current report
May 17, 2021

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Apr 19, 2021

Major Issues Report

8-K - Current report
Mar 31, 2021

Major Issues Report

8-K - Current report
Mar 31, 2021

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 09, 2021

Major Issues Report

8-K - Current report
Dec 07, 2020

Major Issues Report

8-K - Current report
Dec 03, 2020

Major Issues Report

8-K - Current report